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ankle pressure (AP) are shown separately for symptomatic and
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analysis with confounding factors for ABI and AP are also shown.
Dates and causes of death were collected from the Finnish national
statistics registry.
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Value of the data
 Patient cohort consists of 721 patients with symptomatic lower extremity peripheral artery disease
 Analysis of both symptomatic and contralateral ankle brachial index and ankle pressure in relation
to patient outcome
 Data may be used for assessing the role of pressure measurements with respect to patient outcome1. Data
The presented data is acquired from analysis of non-invasive peripheral pressure measurements of
patients with clinically symptomatic (Rutherford 2–6) peripheral artery disease [2,3]. Fig. 1A–D shows
Kaplan-Meier curves for freedom from cardiovascular death and overall survival at defined ABI
categories for both symptomatic and contralateral extremity. Corresponding Kaplan-Meier curves are
presented for ankle pressure in Fig. 2A–D. Cox regression analyses with confounding factors for ABI
and AP are presented in Table 1.2. Experimental design, materials and methods
Present data consists of peripheral pressure measurements in 721 symptomatic PAD patients
admitted to the Department of Vascular Surgery at Turku University Hospital for digital subtraction
angiography between January 2009 and August 2011. Dates and causes of death were collected from
the Finnish national statistics registry at the end of the study period. Baseline demographics were
collected from electronic patient files.2.1. Non-invasive peripheral pressure measurements
Standardised peripheral pressure measurements were obtained in a vascular laboratory at Turku
University Hospital. A Nicolet VasoGuard (Nicolet Vascular inc., Madison, WI, USA) photo-
pletysmography (PPG) device was used for all measurements. Measurements were obtained with
patients in a supine position with feet at heart level. When stable signals were obtained, brachial and
ankle cuffs were inflated until disappearance of the PPG signal. Brachial and ankle pressures were
determined by gradual deflation of the cuffs to the moment of reappearance of a pulsatile signal.2.2. Statistical analysis
All statistical analyses were performed with SPSS version 22 (IBM, Armonk, NY, USA). Survival was
assessed by Kaplan-Meier curves and Log-rank statistics. A Cox regression analysis was performed to
assess the final predictive value of factors affecting survival. Factors with P o 0.2 in Cox univariate
analysis were forced into a Cox proportional hazard model to assess the risk of death.
Fig. 1. A-D Kaplan-Meier curves showing A) cumulative freedom from cardiovascular death and B) overall survival by defined
ABI categories for symptomatic limb. Corresponding Kaplan-Meier curves showing C) cumulative freedom from cardiovascular
death and D) overall survival for contralateral limb. Up to 7 years follow-up. Life tables for 0, 20, 40, 60 and 80 months shown in
lower part of the panels. Pairwise (Wilcoxon) comparison between groups: A) ABI o 0.25 vs. 0.25–0.89: P o 0.001; vs. 0.9–1.3:
P ¼ 0.018; vs. 4 1.3: P ¼ 0.665, ABI 0.25–0.89 vs. 0.9–1.3: P ¼ 0.594; vs. 4 1.3: P o 0.001, ABI 0.9–1.3 vs. 4 1.3: P o 0.001
B) ABI o 0.25 vs. 0.25–0.89: P o 0.001; vs. 0.9–1.3: P ¼ 0.026; vs. 4 1.3: P ¼ 0.707, ABI 0.25–0.89 vs. 0.9–1.3: P ¼ 0.561; vs.
4 1.3: P o 0.001, ABI 0.9–1.3 vs. 4 1.3: P ¼ 0.003 C) ABI o 0.25 vs. 0.25–0.89: P ¼ 0.001; vs. 0.9–1.3: P o 0.001; vs. 4 1.3:
P ¼ 0.428, ABI 0.25–0.89 vs. 0.9–1.3: P ¼ 0.174; vs. 4 1.3: P o 0.001, ABI 0.9–1.3 vs. 4 1.3: P o 0.001 D) ABI o 0.25 vs.
0.25–0.89: P ¼ 0.061; vs. 0.9–1.3: P ¼ 0.012; vs. 4 1.3: P ¼ 0.817, ABI 0.25–0.89 vs. 0.9–1.3: P ¼ 0.061; vs. 4 1.3: P o 0.001,
ABI 0.9–1.3 vs. 4 1.3: P o 0.001.
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Fig. 2. A-D Kaplan-Meier curves showing A) cumulative freedom from cardiovascular death and B) overall survival by defined
AP categories for symptomatic limb. Corresponding Kaplan-Meier curves showing C) cumulative freedom from cardiovascular
death and D) overall survival for contralateral limb. Up to 7 years follow-up. Life tables for 0, 20, 40, 60 and 80 months shown in
lower part of the panels. Pairwise (Wilcoxon) comparison between groups: A) AP (mmHg) o 50 vs. 50–69: P ¼ 0.022; vs.
70–249: P o 0.001; vs. Z 250: P ¼ 0.90, AP (mmHg) 50–69 vs. 70–249: P ¼ 0.68; vs. Z 250: P ¼ 0.014, AP (mmHg) 70–249
vs. Z 250: P o 0.001 B) AP (mmHg) o 50 vs. 50–69: P ¼ 0.123; vs. 70–249: P ¼ 0.001; vs. Z 250: P ¼ 0.263, AP (mmHg)
50–69 vs. 70–249: P ¼ 0.20; vs. Z 250: P ¼ 0.005, AP (mmHg) 70–249 vs. Z 250: P o 0.001 C) AP (mmHg) o 50 vs. 50–69:
P ¼ 0.076; vs. 70–249: P o 0.001; vs. Z 250: P ¼ 0.995, AP (mmHg) 50–69 vs. 70–249: P ¼ 0.63; vs. Z 250: P ¼ 0.008,
AP (mmHg) 70–249 vs. Z 250: P o 0.001 D) AP (mmHg) o 50 vs. 50–69: P ¼ 0.466; vs. 70–249: P ¼ 0.025; vs. Z 250:
P ¼ 0.332, AP (mmHg) 50–69 vs. 70–249: P ¼ 0.011; vs. Z 250: P ¼ 0.003, AP (mmHg) 70–249 vs. Z 250: P o 0.001.
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Table 1
Cox regression analysis for ABI (A) and cardiovascular and overall mortality for symptomatic and contralateral limb. Reference
ABI 0.90-1.30. B) Corresponding Cox regression analysis for AP (B). Reference AP 70-250mmHg. Confounding factors forced into
Cox regression analysis were chosen according to their significance (P o 0.20) in univariate analysis. CAD: coronary artery
disease; HT: hypertension; DM: diabetes, ESRD: end-stage renal disease.
A
HR 95% CI P value
Cardiovascular ABI, symptomatic limb
Age 0.978 0.965–0.992 o 0.01
CAD 1.45 1.09–1.92 0.01
HT 1.27 0.917–1.76 0,.15
DM 1.29 0.967–1.73 0.08
ESRD 1.50 1.01–2.34 0.04
Statin use 0.785 0.585–1.05 0.11
Smoking history 0.474 0.324–0.694 o 0.01
0.90-1.30 Reference
0.25-0.89 1.18 0.679–2.07 0.55
o 0.25 2.31 1.23–4.37 0.01
4 1.30 2.80 1.45–5.39 o 0.01
ABI, contralateral limb
Age 0.984 0.971–0.998 0.02
CAD 1.46 1.10–1.94 o 0.01
HT 1.28 0.926–1.77 0.14
DM 1.20 0.898–1.61 0.22
ESRD 1.58 1.05–2.37 0.03
Statin use 0.689 0.511–0.929 0.02
Smoking history 0.494 0.336–0.725 o 0.01
0.90–1.30 Reference
0.25–0.89 1.44 1.03–2.02 0.04
o 0.25 2.89 1.92–4.34 0.01
4 1.30 3.46 1.63–7.34 o 0.01
Overall ABI, symptomatic limb
Age 0.978 0.968–0.988 o 0.01
CAD 1.17 0.937–1.48 0.17
HT 1.21 0.942–1.54 0.14
DM 1.07 0.852–1.34 0.56
ESRD 1.60 1.17–2.19 o 0.01
Statin use 0.779 0.620–0.980 0.03
Smoking history 0.573 0.436–0.754 o 0.01
0.90–1.30 Reference
0.25–0.89 1.04 0.690–1.57 0.85
o 0.25 1.95 1.16–3.25 0.01
4 1.30 1.97 1.22–3.20 o 0.01
ABI, contralateral limb
Age 0.981 0.971–0.992 o 0.01
CAD 1.18 0.950–1.48 0.13
HT 1.21 0.945–1.55 0.13
DM 1.03 0.819–1.29 0.81
ESRD 1.69 1.22–2.33 o 0.01
Statin use 0.701 0.556–0.885 o 0.01
Smoking history 0.579 0.438–0.763 o 0.01
0.90–1.30 Reference
0.25–0.89 1.41 1.09–1.82 0.01
o 0.25 2.20 1.06–4.57 0.03
4 1.30 2.63 1.91–3.63 o 0.01
B
HR 95% CI P value
Cardiovascular Ankle pressure, symptomatic limb
Age 0.978 0.965–0.992 o 0.01
CAD 1.47 1.11–1.95 o 0.01
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Table 1 (continued )
B
HR 95% CI P value
HT 1.29 0.931–1.79 0.13
DM 1.34 0.998–1.79 0.05
ESRD 1.54 1.03–2.29 0.03
Statin use 0.760 0.567–1.02 0.07
Smoking history 0.482 0.330–0.705 o 0.01
70–249mmHg Reference
50–69mmhg 1.63 1.14–2.33 o 0.01
o 50mmHg 2.18 1.48–3.22 o 0.01
Z 250mmhg 2.30 1.50–3.52 o 0.01
Ankle pressure, contralateral limb
Age 0.987 0.973–1.00 0.05
CAD 1.35 1.02–1.80 0.04
HT 1.24 0.892–1.72 0.20
DM 1.21 0.901–1.62 0.21
ESRD 1.51 1.00–2.27 0.05
Statin use 0.684 0.506–0.924 0.01
Smoking history 0.504 0.343–0.742 o 0.01
70-249mmHg Reference
50-69mmhg 1.63 0.921–2.90 0.09
o 50mmhg 2.93 1.53–5.61 o 0.01
Z 250mmhg 3.39 2.34–4.92 o 0.01
Overall Ankle pressure, symptomatic limb
Age 0.978 0.968–0.989 o 0.01
CAD 1.18 0.950–1.47 0.13
HT 1.22 0.955–1.57 0.11
DM 1.11 0.880–1.39 0.39
ESRD 1.64 1.20–2.25 o 0.01
Statin use 0.758 0.603–0.953 0.02
Smoking history 0.574 0.437–0.853 o 0.01
70-249mmHg Reference
50-69mmhg 1.52 1.16–1.99 o 0.01
o 50mmhg 1.70 1.23–2.35 o 0.01
Z 250mmhg 2.11 1.49–2.97 o 0.01
Ankle pressure, contralateral limb
Age 0.982 0.972–0.993 o 0.01
CAD 1.13 0.904–1.41 0.29
HT 1.19 0.923–1.53 0.18
DM 1.03 0.814–1.29 0.82
ESRD 1.70 1.23–2.35 o 0.01
Statin use 0.687 0.543–0.870 o 0.01
Smoking history 0.602 0.456–0.794 o 0.01
70-249mmhg Reference
50-69mmhg 1.82 0.958–3.44 0.07
o 50mmhg 1.83 1.21–2.78 o 0.01
Z 250mmhg 2.98 2.18–4.05 o 0.01
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